Toy Jake, Tolles Juliana, Bosson Nichole, Hauck Aaron, Abramson Tiffany, Sanko Stephen, Kazan Clayton, Eckstein Marc, Gausche-Hill Marianne, Schlesinger Shira A
Department of Emergency Medicine, Harbor-UCLA Medical Center, Torrance, CA, USA.
The Lundquist Institute, Torrance, CA, USA.
Prehosp Emerg Care. 2024;28(1):98-106. doi: 10.1080/10903127.2023.2172633. Epub 2023 Feb 13.
Rearrest after successful resuscitation from out-of-hospital cardiac arrest (OHCA) is common and is associated with worse patient outcomes. However, little is known about the effect of interventions designed to prevent rearrest. We assessed the association between a prehospital care protocol for immediate management after return of spontaneous circulation (ROSC) and rates of field rearrest and survival to discharge in patients with prehospital ROSC.
This was a retrospective study of adult patients with OHCA and field ROSC within a large EMS system before (April 2017-August 2018) and after (April 2019-February 2020) implementation of a structured prehospital post-ROSC care protocol. The protocol was introduced in September 2018 and provided on-scene stabilization direction including guidance on ventilation and blood pressure support. Field data and hospital outcomes were used to compare the frequency of field rearrest, hospital survival, and survival with good neurologic outcome before and after protocol implementation. Logistic regression was used to assess the association between the post-implementation period and these outcomes, and odds ratios were reported. The association between individual interventions on these outcomes was also explored.
There were 2,706 patients with ROSC after OHCA in the pre-implementation period and 1,780 patients in the post-implementation period. The rate of prehospital rearrest was 43% pre-implementation vs 45% post-implementation (RD 2%, 95% CI -1, 4%). In the adjusted analysis, introduction of the protocol was not associated with decreased odds of rearrest (OR 0.87, 95% CI 0.73, 1.04), survival to hospital discharge (OR 1.01, 95% CI 0.81, 1.24), or survival with good neurologic outcome (OR 0.81, 95% CI 0.61, 1.06). Post-implementation, post-ROSC administration of saline and push-dose epinephrine increased from 11% to 25% (RD 14%, 95% CI 11, 17%) and from 3% to 12% (RD 9% 95% CI 7, 11%), respectively. In an exploratory analysis, push-dose epinephrine was associated with a decreased odds of rearrest (OR 0.68, 95% CI 0.50, 0.94).
Introduction of a post-ROSC care protocol for patients with prehospital ROSC after OHCA was not associated with reduced odds of field rearrest. When elements of the care bundle were considered individually, push-dose epinephrine was associated with decreased odds of rearrest.
院外心脏骤停(OHCA)成功复苏后的再次骤停很常见,且与患者预后较差相关。然而,对于旨在预防再次骤停的干预措施的效果知之甚少。我们评估了院外自主循环恢复(ROSC)后立即进行管理的院前护理方案与院前再次骤停率及院前ROSC患者出院生存率之间的关联。
这是一项对大型急救医疗服务(EMS)系统内成年OHCA且现场ROSC患者的回顾性研究,研究时间为结构化院前ROSC后护理方案实施前(2017年4月至2018年8月)和实施后(2019年4月至2020年2月)。该方案于2018年9月引入,提供现场稳定指导,包括通气和血压支持方面的指导。利用现场数据和医院结局来比较方案实施前后现场再次骤停的频率、医院生存率以及良好神经功能结局的生存率。采用逻辑回归评估实施后时期与这些结局之间的关联,并报告比值比。还探讨了个体干预措施与这些结局之间的关联。
实施前有2706例OHCA后出现ROSC的患者,实施后有1780例。院前再次骤停率在实施前为43%,实施后为45%(风险差2%,95%置信区间-1, 4%)。在调整分析中,方案的引入与再次骤停几率降低(比值比0.87,95%置信区间0.73, 1.04)、出院生存率(比值比1.01,95%置信区间0.81, 1.24)或良好神经功能结局的生存率(比值比0.81,95%置信区间0.61, 1.06)均无关联。实施后,ROSC后生理盐水和推注剂量肾上腺素的使用从11%增加到25%(风险差14%,95%置信区间11, 17%),从3%增加到12%(风险差9%,95%置信区间7, 11%)。在探索性分析中,推注剂量肾上腺素与再次骤停几率降低相关(比值比0.68,95%置信区间0.50, 0.94)。
OHCA后院前ROSC患者引入ROSC后护理方案与现场再次骤停几率降低无关。当单独考虑护理包的各个要素时,推注剂量肾上腺素与再次骤停几率降低相关。